NCT07822581Not yet recruiting
"Discovery2" Study of Using MCG at Emergency Departments
"Discovery2" Study of Using Magnetocardiography (MCG) at Emergency Departments
Source: ClinicalTrials.gov · Last updated 16 Sept 2026
Brief summary (registry, in English)
The purpose of this research is to collect the magnetic signals from the heart to identify features that may help Emergency Department (ED) doctors differentiate high and low risk patients for heart related chest pain.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 1 Sept 2026
- Start date
- 1 Sept 2026
- Primary completion date
- 28 Feb 2027
- Lead sponsor
- SB Technology, Inc.
- Diseases
- Coronary artery disease
- NCT number
- NCT07822581
What you commit to
- Study type: Observational
- Planned participants: 200
- From 1 Sept 2026 to the primary completion date, 28 Feb 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Metallic passive implants that would make the participant unsuitable for MCG (e.g. spinal implants, metal shoulder replacements, dental implants.. etc.)
Other illness
- ST elevation myocardial infarction (STEMI)
- Active arrhythmia (as seen on the most recent ECG) such as atrial fibrillation, atrial flutter, ventricular tachycardia
- Active illegal drug use per history of present illness
- Clear non-ischemic cause for symptoms (e.g. trauma, viral infection, valve disease)
- Clinical conditions that in the opinion of the Investigator would compromise the safety of the participant or ability to complete the protocol (e.g., exceeds bed weight limit, allergy to adhesives)
Other
- Unable to provide informed consent
- Acute hemodynamic instability
- Inability to lie supine and still for 5-10 minutes
- Known or suspected pregnancy
- Unable or unwilling to comply with required follow-up
- Active implantable medical devices (e.g. pacemakers, neurostimulators.. etc.)
- Contraindicated for temporary removal of telemetry during MCG scan
Who the study is looking for
- Women and men aged 22 years and older
- Participant presenting with signs and symptoms suggestive of NSTE-ACS
- In ED chest pain/NSTE-ACS care pathway
- HEART Score 4+
- Have received their first troponin result and can accommodate an MCG scan before the second troponin result.
Age in the registry: 22 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UCSF - Zuckerberg San Francisco General Hospital and Trauma Center Coordinator of this site? Confirm its status | San Francisco | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.